Document is current
Any future updates will be listed below
-
Authors
Conti, Lorenzo
Riccitelli, Gianna C.
Preziosa, Paolo
Vizzino, Carmen
Marchesi, Olga
Rocca, Maria A.
Filippi, Massimo https://orcid.org/0000-0002-5485-0479
-
Funding
Funding for this research was provided by:
Fondazione Italiana Sclerosi Multipla (FISM2018/R/5)
- License Information
-
More Information
Article History
Received: 13 August 2020
Revised: 19 November 2020
Accepted: 19 November 2020
First Online: 2 January 2021
Compliance with ethical standards
:
: L. Conti, G.C. Riccitelli, C. Vizzino, O. Marchesi have nothing to disclose. P. Preziosa received speaker honoraria from Biogen Idec, Novartis, Merck-Serono and ExceMED. M.A Rocca received speaker honoraria from Biogen Idec, Novartis, Genzyme, Teva, Merck Serono, Roche, Celgene and Bayer and receives research support from the Italian Ministry of Health, MS Society of Canada and Fondazione Italiana Sclerosi Multipla. M. Filippi is Editor-in-Chief of the Journal of Neurology; received compensation for consulting services and/or speaking activities from Bayer, Biogen Idec, Merck-Serono, Novartis, Roche, Sanofi Genzyme, Takeda, and Teva Pharmaceutical Industries; and receives research support from Biogen Idec, Merck-Serono, Novartis, Roche, Teva Pharmaceutical Industries, Italian Ministry of Health, Fondazione Italiana Sclerosi Multipla, and ARiSLA (Fondazione Italiana di Ricerca per la SLA).
: Approval was received from local ethical standards committee on human experimentation and written informed consent was obtained from all subjects prior to study participation.
: All participants gave informed consent to participate in the current study, and they also gave informed consent for publishing any research work from their data.
